Introduction
In the present study we provide evidence that activa-Measurement of arachidonic acid release tion of the alternative pathway of complement on the The release of 14C-arachidonic acid (14C-AA) from cellular surface of cultured PTEC leads to the arachidonic acid lipids, mainly phospholipids, was measured using the method mobilization with production of autacoids and to the described by Hirata et al. [9] : 5×105 cells were incubated in synthesis of proinflammatory cytokines.
2 ml with 0.15 mCi 14C-AA ( 55.5 Ci/mol ) at 37°C for 1 h. The cells were washed twice with modified Grey's buffer and incubated in 2 ml of the same buffer. The release was measured after treatment with different stimuli at 37°C .
Subjects and methods

Measurement of prostaglandin E 2 and cytokines Proximal tubule epithelial cell preparation and characterization
The release of prostaglandin E 2 (PGE 2] by PTEC incubated with NHS or HIHS was studied using an enzyme immunoSurgical specimens of kidneys were used as the source for assay system (BIOTRAK, Amersham Life Science, establishing cultures. The fibrous capsule was removed and Amersham UK). The production of TNF-a and IL-6 was portions of tissue were dissected from the outer cortex, evaluated by ELISA (Quantikine, R&D Systems, minced, and forced through a graded series of meshes to Minneapolis MN ). remove interstitial fragments and glomeruli. PTEC were pelleted, resuspended, and plated in RPMI 1640 supple-
Results
mented with 17% heat-inactivated fetal calf serum (Sigma), 50 U/ml penicillin, and 50 mg/ml streptomycin. Endotoxin was not detectable in either preparation when tested by Generation of inflammatory mediators subsequent to limulus assay. PTEC were characterized, as previously the activation of the alternative pathway of compledescribed [4] , on the basis of: (a) minimal staining for desmin ment on the PTEC surface, was studied using a concenand negative staining for factor VIII-vWF; (b) strong stain-tration of NHS that was found sublytic in preliminary ing for cytokeratin and actin ; (c) staining of 90-96% of cells experiment [6 ] . PTEC incubated with 5% NHS but Experiments were performed on confluent monolayers at the 4th-5th passage in culture to avoid monocyte contamina-P-bromodiphenacyl bromide, an inhibitor of PLA 2 tion. The results obtained from PTEC cultured from four [10] , prevented the mobilization of 14C-AA (Figure 2 ). different donors were comparable. Each individual experi-The role of extracellular Ca2+ in stimulating 14C-AA ment was performed in triplicate.
release by PLA 2 activation was suggested by the inhibitory effect on 14C-AA release in PTEC incubated with Mg2+/EGTA-HS ( Figure 2 ) that chelates calcium from Source of complement extracellular medium. Mg2+/EGTA-HS did not interfere with the fixation of complement by alternative For in vitro experiments the following sera were used as pathway on PTEC surface [6 ] . activity was obtained after addition of 50 mg/ml human of C6 Def HS with purified human C6 restored the purified C6 (Sigma) to C6-def HS. Formation of C5b-9 14C-AA release. The production of autacoids following neoantigen on PTEC cell surface was detected by immuno-the AA release was assessed by measuring the release fluorescence using a monoclonal antibody anti-human C5b-9 of PGE 2 . NHS but not HIHS stimulated a sustained neoantigen ( Dako spa, Milano, Italy) as previously production of PGE 2 by PTEC ( Figure 5 ).
described [6 ] Measurements of cytokines into cell-free supernatants indicate that NHS, but not HIHS, stimulates the production of TNF-a ( Figure 6a ) and IL-6 Measurement of calcium influx (Figure 6b ). The dependency of cytokine synthesis on the fixation of terminal components of complement The extracellular Ca2+ uptake was evaluated using 45Ca2+ was shown by using C6-def HS and by restoring the [ 8] Cells ( 5×105/ml ), incubated in the balanced-salt solution ability to form MAC after addition of purified C6 several studies performed on tissue sections [4, 5] and that complement, once filtered through the glomerular barrier, may be activated by the brush border of on primary cultures [6, [11] [12] [13] The physiological function of this enzymatic activity is unclear but is probably proximal tubules. The increased urinary excretion of C3 and MAC may reflect this phenomenon. Deposition related to the cleavage of other substrates since complement components are normally not filtered into the of C3 and C5b-9 along the luminal border of proximal tubular cells was found in aminonucleoside nephrosis urine unless in the presence of gross alteration of glomerular permeability.
and overload proteinuria [7, 17] . These experimental models in which no glomerular activation of compleIndeed, studies on patients with non-selective proteinuria demonstrated the occurrence of tubular C3 ment is seen and in which is absent an antibodymediated mechanism of complement fixation, strongly deposits which positively correlated to the urinary complement excretion [14 ] . Moreover, C3 excreted in suggest that complement activation of proximal tubuli may occurr in vivo during proteinuria. At variance, the urine of proteinuric patients, was shown to be capable of undergoing activation [14 ] . Recently, the Schulze et al. [18] have shown an overexcretion of C5b-9 strictly confined to experimental immunological urinary excretion of C5b-9 MAC neoantigen and its deposition in tubular epithelium was detected in pro-injury of podocytes. In these experiments they have corrected the urinary C5b-9 excretion for 'non-specific' teinuric nephropathies either in the presence or absence of MAC glomerular deposits [15, 16 ] . This suggests excretion of C5b-9 due to proteinuria. In fact the increased glomerular permeability occurring in proteinuric conditions may favour an increased urinary excretion of C5b-9, which is normally detectable within the circulation. Recently it has been shown that in human renal infarction activation of complement and insertion of terminal components of complement may occur within the proximal tubules when complement components enter in the intratubular urinary space of ischaemic tubules [19] . It has been suggested that the for 2 h with HIHS, NHS, C6-def HS, or C6-def HS reconstitued with human purified C6.
activation of complement may depend either on the endothelium adhesion, fibroblast activation and extracellular matrix formation, either by acting directly or through the synthesis of several secondary mediators. IL-6 was shown to share with TNF several inflammatory properties as well as to posses specific regulatory role in growth and differentiation of different target cell types [26 ] .
The mobilization of AA observed in the present study was related to an influx of extracellular Ca2+ and to the activation of PLA 2 , since this phenomenon is inhibited by Mg2+/EGTA and by p-bromodiphenacyl bromide, an inhibitor of PLA 2 . Both the release of AA and the synthesis of cytokines occurred as consequences of complement activation and fixation of MAC on PTEC surface. Indeed, when PTEC were incubated with C6-def HS, which is unable to fix the terminal component of complement and form MAC on the cell surface, no significant release of AA or production of cytokines was observed. The ability to fix the terminal components of complement and to induce AA release and cytokine production was restored by purified C6. The present experiments cannot precisely indicate which of the terminal components of complement is primarily involved in cell Fig. 7 . Synthesis of (a) TNF-a and (b ) IL-6 by PTEC incubated at stimulation, since beside C5b-9 also C5b-7 and 37°C for 6 h with 5% NHS, C6-def HS, or C6-def HS reconstitued C5b-8 may display biological activity [27] . Moreover, with human purified C6.
we observed a complement-induced release of PGE 2 . PGE 2 , a metabolite of cyclooxygenase-dependent presence of a C3 convertase in the brush border of metabolic pathway of AA, may either amplify or proximal tubules or on the release of proteases in the inhibit the inflammatory phenomena [28 ] . Indeed it ischaemic tissue [19] . Tubulointerstitial deposits of has been reported that PGE 2 in association of complecomplement have been also related to an interstitial ment-derived bioactive peptides significantly enhances activation of complement by ammonia [20 ] and to a vascular permeability at the site of inflammation [28 ] . cytokine-inducible synthesis of C3 by PTEC [21 ] .
On the other hand, PGE 2 inhibits the activation and Whether the fixation of complement on the surface the recruitment of inflammatory cells [28] . In the of PTEC is a confined phenomenon or else contributes present study we evaluated the PGE 2 as a marker of to the pathogenesis of the tubular interstitial injury by production of AA-derived bioactive metabolites. We triggering generation of inflammatory mediators is cannot exclude that other cyclooxigenase or lipoxigenunknown. The present work supports the hypothesis ase metabolites, not considered in this study but potenthat complement activation on the surface of tubular tially relevant for the modulation of inflammatory cells may generate mediators that can be instrumental reaction, are produced during complement activation in the induction of tubulointerstitial injury. It is well on PTEC. known that the insertion of C5b-9 generated by an The vulnerability of PTEC to complement injury antigen-antibody reaction on the surface of various may also reflect the absence or scarcity on their brush cell type has a stimulatory action [22] [23] [24] . However, border of complement regulatory proteins such as the results of the present study indicate that PTEC, in CD55 and CD46, that inhibit the complement activathe absence of an antibody-mediated mechanism are tion cascade at C3 convertase level, and CD59, that per se capable of activating complement and fixing inhibits the formation of MAC. Morphological studies C5b-9 on their surface as results of the contact of have shown that complement regulatory proteins on complement component with a C3-convertase present the surface of PTEC are mainly restricted to the on PTEC surface. Therefore, we investigated whether basolateral site [29] . the complement activation on PTEC surface could
The results of the present study suggest that complestimulate generation of inflammatory mediators. Our ment activation on the cell surface and insertion of the attention was focused on the release of AA, which is terminal components of complement may trigger the the precursor of potent autacoids, and of TNF-a and generation of proinflammatory mediators from PTEC IL-6, cytokines which mediate several vascular and in vitro. cellular events of inflammation. TNF-a, in particular, One can speculate that in patients with compleis a homotrimeric polypeptide with a wide range of menturia due to non-selective proteinuria, PTEC may biological activities [25 ] . This cytokine was shown to directly participate in the activation of complement be involved in several steps of the inflammatory process such as vascular permeability alteration, leukocyte-cascade at the luminal site of proximal tubules, leading
